The prognostic value of stress tests in chronic heart failure

Cardiology Journal

Volumn 14, Issue 4, 2007, Pages 340-346

  Piechota, Wiktor ^a,b   Gielerak, Grzegorz ^a  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

^b NONE   (Poland)

Author keywords

Biomarkers; Cardiopulmonary exercise testing; Heart failure; Prognosis; Stress echocardiography

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; DOBUTAMINE;

BODY MASS; CARDIOPULMONARY HEMODYNAMICS; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; EXERCISE TEST; HEART CONTRACTION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; MITRAL VALVE REGURGITATION; MORTALITY; PATIENT SAFETY; PRIMARY PREVENTION; PROGNOSIS; PULMONARY HYPERTENSION; RADIOCARDIOGRAPHY; REVIEW; RISK ASSESSMENT; SECONDARY PREVENTION; STRESS ECHOCARDIOGRAPHY; SURVIVAL RATE; SURVIVAL TIME; SYSTOLIC BLOOD PRESSURE; TREATMENT INDICATION;

EID: 34648817076     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Straburzyńska-Migaj E, Szyszka A, Cieśliński A. Exercise testing in heart failure; utility and limitations. Kardiol Pol, 2003; 58: 77-79.
2. Clark AL, Poole-Wilson PA, Coats A. Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol, 1996; 28: 1092-1102.
3. Weber K, Kinasewitz G, Janicki J, Fishman AP. Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure. Circulation, 1982; 65: 1213-1223.
4. Szlachcic J, Massie BM, Kramer BL, Topic N, Tubau J. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol, 1985; 55: 1037-1042.
5. Likoff MJ, Chandler SL, Kay HR. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic or dilated cardiomyopathy. Am J Cardiol, 1987; 56: 634-638.
6. Lamblin N, Mouquet F, Hennache B et al. High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failure. Eur Heart J, 2005; 26: 2245-2250.
7. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr., Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation, 1991; 83: 778-786.
8. Working Group on Cardiac Rehabilitation and Exercise Physiology and Working Group on Heart Failure of the European Society of Cardiology. Recommendations for exercise testing in CHF patients. Eur Heart J, 2001; 22; 37-45.
9. Lainchbury JG, Richards AM. Exercise testing in the assessment of chronic congestive heart failure. Heart, 2002; 88: 538-543.
10. Aaronson KD, Mancini DM. Is percentage of predicted maximal exercise oxygen consumption a better predictor of survival than peak exercise oxygen consumption for patients with severe heart failure? J Heart Lung Transplant, 1995; 14: 981-989.
11. Stelken AM, Younis LT, Jennison SH et al. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J Am Coll Cardiol, 1996; 27: 345-352.
12. Osada N, Chaitman BR, Miller LW et al. Cardiopulmonary exercise testing identifies low risk patients with heart failure and severely impaired exercise capacity considered for heart transplantation. J Am Coll Cardiol, 1998; 31: 577-582.
13. Milani RV, Lavie CJ, Mehra MR. Cardiopulmonary exercise testing: how do we differentiate the cause of dyspnea? Circulation, 2004; 110: e27-e31.
14. Chua T, Ponikowski P, Harrington D et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol, 1997; 29: 1585-1590.
15. Pardaens K, Van Cleemput J, Vanhaecke J, Fagard RH. Peak oxygen uptake better predicts outcome than submaximal respiratory data in heart transplant candidates. Circulation, 2000; 101: 1152-1157.
16. Jankowska EA, Pietruk-Kowalczyk J, Zymliński R et al. The role of exercise ventilation in clinical evaluation and risk stratification in patients with chronic heart failure. Kardiol Pol, 2003; 59: 115-127.
17. Cohen-Solal A, Barnier P, Pessione F et al. Comparison of the long-term prognostic value of peak exercise oxygen pulse and peak oxygen uptake in patients with chronic heart failure. Heart, 1997; 78: 572-576.
18. Cohen-Solal A, Tabet JY, Logeart D, Bourgoin P, Tokmakova M, Dahan M. A non-invasively determined surrogate of cardiac power ('circulatory power') at peak exercise is a powerful prognostic factor in chronic heart failure. Eur Heart J, 2002; 23: 806-814.
19. Williams S, Jackson M, Ng LL, Barken D, Patwala A, Tan L-B. Exercise duration and peak systolic blood pressure are predictive of mortality in ambulatory patients with mild-moderate chronic heart failure. Cardiology 2005; 104: 221-226.
20. Paraskevaidis IA, Adamopoulos S, Kremastinos DT. Dobutamine echocardiographic study in patients with nonischemic dilated cardiomyopathy and prognostically borderline values of peak exercise oxygen consumption: 18-month follow-up study. J Am Coll Cardiol, 2001; 37: 1685-1691.
21. Agricola E, Oppizzi M, Pisani M, Margonato A. Stress echocardiography in heart failure. Cardiovasc Ultrasound, 2004; 2: 11.
22. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation, 1997; 95: 2660-2667.
23. Gardner RS, Ozalp F, Murday AJ, Robb SD, McDonagh TA. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J, 2003; 24: 1735-1743.
24. de Groote P, Dagorn J, Soudan B, Lamblin N, McFadden E, Bauters C. B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. J Am Coll Cardiol, 2004, 43: 1584-1589.
25. Lainchbury JG, Swanney MP, Beckert L. Change in plasma brain natriuretic peptide during exercise is an important predictor in systolic heart failure. Eur Heart J, 2001; 22 (suppl.): 377.
26. Ridker PM. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit. Am Heart J, 2004; 148 (1 suppl.): S19-S26.